Mats Heyman
Clinical trials sponsored by Mats Heyman, explained in plain language.
-
Massive new study aims to outsmart childhood leukemia
Disease control Recruiting nowThis study is testing a new, comprehensive treatment plan for children and young adults (ages 0-45) newly diagnosed with acute lymphoblastic leukemia (ALL). It combines the best approaches from previous successful treatments to improve survival and reduce side effects. The study …
Phase: PHASE3 • Sponsor: Mats Heyman • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pilot study aims to improve leukaemia treatment for young patients
Knowledge-focused Recruiting nowThis pilot study is for children and young adults (0-45 years) newly diagnosed with acute lymphoblastic leukaemia (ALL). It collects information on standard treatments already used in clinics to help prepare for future research trials. The study involves 500 participants and focu…
Sponsor: Mats Heyman • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:44 UTC